iPSCs-based platforms, engineered to propel allogeneic cell therapies to clinic with high efficiency and acuity at every step.

About

Related projects

Projects

Learn more

Macrotwin

    R&D Advanced Therapies

En cours

Learn more

Fundrop

    R&D Advanced Therapies

En cours

Learn more

iCone

    R&D Biopharma

Terminé

Related news

News

Learn more

Cellistic Launches Three New iPSC-based GMP Manufacturing Platforms to advance Immuno-Oncology and Regenerative Cell Therapies

    Press release

14.01.2026

Learn more
Cellistic

Cellistic launches Allo Chassis™: Ready-to-use, immune-cloaked iPSC Cell Lines facilitating cost-effective cell therapy development

    Press release

18.02.2025